Clinicians should selectively offer screening to adults 76 to 85 years of age. Clinician hope new guidelines will catch the cancer earlier in those under 50.
Simulations shed light on heart-scarring similarities among patients with atrial fibrillation and those who had embolic stroke but no atrial fibrillation.